These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 33818756)
1. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Sasaki K; Ravandi F; Kadia TM; DiNardo CD; Short NJ; Borthakur G; Jabbour E; Kantarjian HM Cancer; 2021 Jun; 127(12):2049-2061. PubMed ID: 33818756 [TBL] [Abstract][Full Text] [Related]
2. Elderly patients with acute myeloid leukemia who only receive supportive care in the Surveillance, Epidemiology and End Results-Medicare database: demographics, treatment patterns and outcomes. Dharmani C; Wang E; Tu N; Fofah O; Cueto J; Salas M; Kamel YM Future Oncol; 2023 Aug; 19(24):1677-1693. PubMed ID: 37345543 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes of elderly patients with acute myeloid leukemia who receive no treatment in the Surveillance, Epidemiology and End Results-Medicare database. Dharmani C; Wang E; Tu N; Salas M; Kamel YM Future Oncol; 2023 Jan; 19(2):159-171. PubMed ID: 36912693 [TBL] [Abstract][Full Text] [Related]
4. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era. Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657 [TBL] [Abstract][Full Text] [Related]
5. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Thein MS; Ershler WB; Jemal A; Yates JW; Baer MR Cancer; 2013 Aug; 119(15):2720-7. PubMed ID: 23633441 [TBL] [Abstract][Full Text] [Related]
6. Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt. Sedeta E; Jemal A; Nisotel L; Sung H Cancer; 2024 Jun; 130(11):1952-1963. PubMed ID: 38244208 [TBL] [Abstract][Full Text] [Related]
7. Trends in leukemia incidence and survival in the United States (1973-1998). Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476 [TBL] [Abstract][Full Text] [Related]
8. Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013. Song X; Peng Y; Wang X; Chen Y; Jin L; Yang T; Qian M; Ni W; Tong X; Lan J Acta Haematol; 2018; 139(2):115-127. PubMed ID: 29455198 [TBL] [Abstract][Full Text] [Related]
9. Improved survival among older acute myeloid leukemia patients - a population-based study. Shah BK; Ghimire KB Acta Oncol; 2014 Jul; 53(7):935-8. PubMed ID: 24913154 [TBL] [Abstract][Full Text] [Related]
10. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Pulte D; Jansen L; Castro FA; Krilaviciute A; Katalinic A; Barnes B; Ressing M; Holleczek B; Luttmann S; Brenner H; Int J Cancer; 2016 Sep; 139(6):1289-96. PubMed ID: 27176899 [TBL] [Abstract][Full Text] [Related]
11. Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009. Bailey C; Richardson LC; Allemani C; Bonaventure A; Harewood R; Moore AR; Stewart SL; Weir HK; Coleman MP; Cancer; 2018 Oct; 124(19):3856-3867. PubMed ID: 30343495 [TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia: A population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017. Sasaki K; Jabbour E; Short NJ; Jain N; Ravandi F; Pui CH; Kantarjian H Am J Hematol; 2021 Jun; 96(6):650-658. PubMed ID: 33709456 [TBL] [Abstract][Full Text] [Related]
13. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data. Hossain MJ; Xie L Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618 [TBL] [Abstract][Full Text] [Related]
14. Second primary malignancies in adult acute myeloid leukemia--A US population-based study. Ghimire KB; Shah BK Anticancer Res; 2014 Jul; 34(7):3855-9. PubMed ID: 24982414 [TBL] [Abstract][Full Text] [Related]
15. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis. Zeidan AM; Podoltsev NA; Wang X; Bewersdorf JP; Shallis RM; Huntington SF; Gore SD; Davidoff AJ; Ma X; Wang R Cancer; 2019 Dec; 125(23):4241-4251. PubMed ID: 31483484 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: evidence from four decades of US population data. Hossain MJ; Xie L; Caywood EH Cancer Epidemiol; 2015 Oct; 39(5):720-6. PubMed ID: 26159683 [TBL] [Abstract][Full Text] [Related]
18. Survival differences in childhood and young adult acute myeloid leukemia: A cross-national study using US and England data. Xie S; Hossain MJ Cancer Epidemiol; 2018 Jun; 54():19-24. PubMed ID: 29554538 [TBL] [Abstract][Full Text] [Related]
19. Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database. Qasrawi A; Gomes V; Chacko CA; Mansour A; Kesler M; Arora R; Wei S; Ramlal R; Munker R Leuk Res; 2020 Feb; 89():106301. PubMed ID: 31982153 [TBL] [Abstract][Full Text] [Related]